The Effect of Sodium-glucose Cotransporter (SGLT) 2 Inhibitors on Cystine Stone Formation: A Preliminary Study
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Dapagliflozin
Related studies linked through entity extraction aliases.
GliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation Trial
- Status
- UNKNOWN
- Phase
- PHASE4
Use of Dapagliflozin to Reduce Burden of Atrial Fibrillation in Patients Undergoing Catheter Ablation of Symptomatic Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Dapagliflozin on LV Remodeling Post AMI
- Status
- UNKNOWN
- Phase
- PHASE4
Dapagliflozin to Prevent Atrial Fibrillation Recurrence After Transcatheter Pulmonary Venous Isolation.
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Dapagliflozin Effect on Cardiovascular Outcomes in Haemodialysis for End Stage Renal Disease
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
EFFECT OF ADDING DAPAGLIFLOZIN TO ALLOGRAFT DYSFUNCTION OF RENAL TRANSPLANTED PATIENTS.
- Status
- COMPLETED
- Phase
- PHASE4
Dapagliflozin (DAPA) Effects in HFpEF
- Status
- COMPLETED
- Phase
- PHASE2
Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)
- Status
- COMPLETED
- Phase
- PHASE2
Impact on Atrial Remodeling of Dapaglifozin in Patients With Heart Failure .
- Status
- COMPLETED
- Phase
- PHASE3
Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS)
- Status
- RECRUITING
- Phase
- PHASE4
A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin
- Status
- UNKNOWN
- Phase
- PHASE4
SGLT2-Inhibitors for Sleep Apnea in Heart Failure
- Status
- WITHDRAWN
- Phase
- PHASE2
The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes.
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease
- Status
- COMPLETED
- Phase
- PHASE2
Dapagliflozin on Hypotensive Heart Failure Patients After Sacubitril/Valsartan Therapy
- Status
- COMPLETED
- Phase
- PHASE4
Dapagliflozin And Pulmonary Artery Hemodynamics in Heart Failure With Reduced Ejection Fraction Patients With CardioMEMS®
- Status
- UNKNOWN
- Phase
- PHASE4
Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack.
- Status
- COMPLETED
- Phase
- PHASE3
Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Dapagliflozin in Children With Proteinuria
- Status
- COMPLETED
- Phase
- PHASE4